Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay (Q38968633)

8 September 2017

title

Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay (English)

1 reference

Human T-lymphotropic virus 1

8 September 2017

main subject

0 references

2

Raymond Césaire

1 reference

8 September 2017

1

Axelle Dehée

1 reference

8 September 2017

Nathalie Désiré

3

1 reference

8 September 2017

Agnès Lézin

4

1 reference

8 September 2017

Olivier Bourdonné

5

1 reference

8 September 2017

Odile Béra

6

1 reference

8 September 2017

Yves Plumelle

7

1 reference

8 September 2017

Didier Smadja

8

1 reference

8 September 2017

Jean Claude Nicolas

9

1 reference

8 September 2017

publication date

1 April 2002

1 reference

Journal of Virological Methods

8 September 2017

published in

1 reference

8 September 2017

volume

102

1 reference

8 September 2017

issue

1-2

1 reference

8 September 2017

page(s)

37-51

1 reference

Quantification of human T-cell lymphotropic virus type 1 proviral load by quantitative competitive polymerase chain reaction

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

Quantification of HTLV-II proviral copies by competitive polymerase chain reaction in peripheral blood mononuclear cells of Italian injecting drug users, central Africans, and Amerindians

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

Absence of human T-lymphotropic virus type I tax sequences in a population of normal blood donors in the Baltimore, MD/Washington, DC, area: results from a multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

HTLV-I provirus in seronegative Chilean patients with tropical spastic paraparesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

Real time quantitative PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

Predictors of level of circulating abnormal lymphocytes among human T-lymphotropic virus type I carriers in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

Genomic structure of HTLV (human T-cell leukemia virus): detection of defective genome and its amplification in MT-2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

Polymerase chain reaction analysis of defective human T-cell leukemia virus type I proviral genomes in leukemic cells of patients with adult T-cell leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

HTLV-I-seronegative, genome-positive adult T-cell leukemia: report of a case.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis patients treated with humanized anti-Tac

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

The epidemiology of the human T-cell lymphotrophic virus type I and type II: etiologic role in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

Quantitation of HTLV-I provirus among seropositive blood donors: relation with antibody profile using synthetic peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

Real-time polymerase chain reaction assay for cell-associated HTLV type I DNA viral load.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

Increased human T lymphotropic virus type-1 (HTLV-1) proviral DNA in peripheral blood mononuclear cells and bronchoalveolar lavage cells from Japanese patients with HTLV-1-associated myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

Dependency of antibody titer on provirus load in human T lymphotropic virus type I carriers: an interpretation for the minor population of seronegative carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

HTLV-I associated myelopathy, a new clinical entity.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

Human T cell leukemia virus type I (HTLV-I) molecular genotypes and disease outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

Frequent mutation in pX region of HTLV-1 is observed in HAM/TSP patients, but is not specifically associated with the central nervous system lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

Mutation rates in LTR of HTLV-1 in HAM/TSP patients and the carriers are similarly high to Tax/Rex-coding sequence.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

Prospective study of HTLV-I infection in an initially asymptomatic cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

Quantification of proviral DNA load in human T-cell leukaemia virus type I infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

Human T Lymphotropic Virus (HTLV) Type I and II DNA Amplification in HTLV-I/II-Seropositive Blood Donors of the French West Indies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

Clonal expansion of infected cells: a way of life for HTLV-I.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

Increased replication of HTLV-I in HTLV-I-associated myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900445-1

7 January 2021

10.1016/S0166-0934(01)00445-1

Identifiers

DOI

1 reference

8 September 2017

1 reference